5-((2-(Allylamino)-9-methyl-4-oxo-4H-pyrido[1,2-a]pyrimidin-3-yl)methylene)-2-thioxothiazolidin-4-one

Catalog No. :
ACZXPQ066
CAS No. :
372499-71-3
Molecular Formula :
C16H14N4O2S2
Molecular Weight :
358.45

IUPAC Name:(Z)-5-((2-(allylamino)-9-methyl-4-oxo-4H-pyrido[1,2-a]pyrimidin-3-yl)methylene)-2-thioxothiazolidin-4-one

5-((2-(Allylamino)-9-methyl-4-oxo-4H-pyrido[1,2-a]pyrimidin-3-yl)methylene)-2-thioxothiazolidin-4-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-((2-(Allylamino)-9-methyl-4-oxo-4H-pyrido[1,2-a]pyrimidin-3-yl)methylene)-2-thioxothiazolidin-4-one
IUPAC Name(Z)-5-((2-(allylamino)-9-methyl-4-oxo-4H-pyrido[1,2-a]pyrimidin-3-yl)methylene)-2-thioxothiazolidin-4-one
Molecular FormulaC16H14N4O2S2
Molecular Weight358.45
SMILESO=C1C(/C=C(SC(N2)=S)/C2=O)=C(NCC=C)N=C3N1C=CC=C3C
InChI KeyAQEUNUMFCNNMOF-FLIBITNWSA-N
SynonymSALOR-INT L247952-1EA;2-(ALLYLAMINO)-9-METHYL-3-[(Z)-(4-OXO-2-THIOXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]-4H-PYRIDO[1,2-A]PYRIMIDIN-4-ONE;4H-Pyrido[1,2-a]pyrimidin-4-one, 9-methyl-3-[(4-oxo-2-thioxo-5-thiazolidinylidene)methyl]-2-(2-propen-1-ylamino)-
CAS No.372499-71-3

Synthetic Route by SureRoute

1. ACZXPQ066 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACADET348 route compound structure diagram
    ACADET348141-84-4 In Stock
  4. Then
  5. ACZXPQ066 route product structure diagram
    ACZXPQ066372499-71-3
Inquiry

2. ACZXPQ066 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACXLTP679 route compound structure diagram
    ACXLTP67910017-11-5 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACZXPQ066 route product structure diagram
    ACZXPQ066372499-71-3
Inquiry

Comments (0)